No Data
No Data
Eton Pharmaceuticals to Host Virtual Investor Day and Release Fourth Quarter Earnings Results on March 18, 2025
Eton Pharmaceuticals Releases FDA-Approved Galzin Capsules for Long-Term Wilson Disease Management
Express News | Eton Pharmaceuticals- Eton Cares to Offer $0 Co-Pay for Eligible Patients for Galzin Capsules
Express News | Eton Pharmaceuticals Announces Commercial Launch of Galzin® (Zinc Acetate) Capsules
Eton Pharmaceuticals Announces Commercial Launch of Galzin (Zinc Acetate) Capsules
Eton Pharmaceuticals Down Over 10%, on Pace for Largest Percent Decrease Since March 2024 -- Data Talk